Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
74 studies found for:    Open Studies | "Diabetic Retinopathy"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Diabetic Retinopathy"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Diabetic Retinopathy Screening in Private Practice
Condition: Diabetic Retinopathy
Interventions: Other: Free screening group;   Other: Pay screening group ($150);   Other: Pay screening group ($300)
2 Recruiting Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of Hyperglycemia
Condition: Diabetic Retinopathy
Intervention: Other: Initiation of treatment of diabetes
3 Recruiting Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery
Condition: Diabetic Retinopathy
Interventions: Drug: Aflibercept;   Drug: Sham
4 Not yet recruiting Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Aflibercept
5 Recruiting Analysis of Angiogenic Factor Levels in Eyes With Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention:
6 Recruiting The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Drug: Intravitreal Aflibercept injection
7 Recruiting Progression of Diabetic Retinopathy. Identification of Signs and Surrogate Outcomes
Condition: Diabetic Retinopathy
Intervention:
8 Recruiting Genetic Markers and Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Genetic: genetic analysis
9 Recruiting Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Aflibercept
10 Recruiting 25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide
11 Recruiting Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: emixustat hydrochloride;   Other: Placebo
12 Recruiting Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: ranibizumab;   Drug: sham;   Procedure: pars plana vitrectomy
13 Recruiting Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
Condition: Nonproliferative Diabetic Retinopathy
Interventions: Drug: Intravitreal aflibercept injection [IAI];   Drug: Sham
14 Recruiting Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy
Condition: Non-proliferative Diabetic Retinopathy
Interventions: Drug: Compound danshen dripping pills;   Drug: Placebo
15 Recruiting Comparison of Interval Variation and Dosage in Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy
Condition: Proliferative Diabetic Retinopathy, Pars Plana Vitrectomy, Intravitreal Bevacizumab
Intervention: Drug: Intravitreal bevacizumab
16 Recruiting A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy
Condition: Non-Proliferative Diabetic Retinopathy
Interventions: Drug: 1.0mg Luminate®;   Drug: 2.0mg Luminate®;   Drug: 3.0mg Luminate®;   Other: Balanced Salt Solution for intravitreal injection in 0.10cc
17 Recruiting Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
Conditions: Diabetic Retinopathy;   HIV
Interventions: Drug: Tesamorelin;   Drug: Placebo-Control
18 Recruiting CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea
Conditions: Diabetic Retinopathy;   Sleep Apnea
Interventions: Device: Continuous positive airway pressure;   Drug: Pharmacological treatment;   Other: Conventional anti-diabetic diet recommendations
19 Recruiting Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: Aflibercept;   Procedure: Endolaserless Vitrectomy
20 Recruiting 25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.